These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


333 related items for PubMed ID: 11358938

  • 1. Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats.
    Nakamura Y, Ono H, Zhou X, Frohlich ED.
    Hypertension; 2001 May; 37(5):1262-7. PubMed ID: 11358938
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME.
    Francischetti A, Ono H, Frohlich ED.
    Hypertension; 1998 Mar; 31(3):795-801. PubMed ID: 9495263
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    J Hypertens; 2002 May; 20(5):993-1000. PubMed ID: 12011661
    [Abstract] [Full Text] [Related]

  • 8. Renoprotective effects of omapatrilat are mediated partially by bradykinin.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2003 May; 23(4):214-21. PubMed ID: 12789027
    [Abstract] [Full Text] [Related]

  • 9. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S, Kitakaze M, Node K, Takashima S, Ogai A, Asanuma H, Sakata Y, Asakura M, Ogita H, Liao Y, Fukushima T, Yamada J, Minamino T, Kuzuya T, Hori M.
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [Abstract] [Full Text] [Related]

  • 10. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model.
    Zhou X, Ono H, Ono Y, Frohlich ED.
    Am J Nephrol; 2004 Sep; 24(2):242-9. PubMed ID: 15031627
    [Abstract] [Full Text] [Related]

  • 11. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM, Robertson SJ, Burns KD, deBlois D.
    Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
    [Abstract] [Full Text] [Related]

  • 12. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
    Biwer LA, Broderick TL, Xu H, Carroll C, Hale TM.
    Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
    [Abstract] [Full Text] [Related]

  • 13. Influence of irbesartan and enalapril on changes of renal function associated with the established phase of l-NAME hypertension.
    Jover B, Herizi A, Casellas D, Mimran A.
    J Hypertens; 2001 Nov; 19(11):2039-46. PubMed ID: 11677370
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M, Finckenberg P, Pere AK, Krogerus L, Ahonen J, Vapaatalo H, Nurminen ML.
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [Abstract] [Full Text] [Related]

  • 17. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
    Zappellini A, Teixeira SA, Muscará MN, Zatz R, Antunes E, De Nucci G.
    Eur J Pharmacol; 1996 Dec 19; 317(2-3):285-91. PubMed ID: 8997612
    [Abstract] [Full Text] [Related]

  • 18. Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.
    Ono Y, Ono H, Frohlich ED.
    J Hypertens; 1996 Jul 19; 14(7):823-8. PubMed ID: 8818920
    [Abstract] [Full Text] [Related]

  • 19. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
    De Gennaro Colonna V, Fioretti S, Rigamonti A, Bonomo S, Manfredi B, Muller EE, Berti F, Rossoni G.
    J Hypertens; 2006 Jan 19; 24(1):95-102. PubMed ID: 16331106
    [Abstract] [Full Text] [Related]

  • 20. Imidapril improves L-NAME-exacerbated nephrosclerosis with TGF-beta 1 inhibition in spontaneously hypertensive rats.
    Ono H, Saitoh M, Ono Y, Ishimitu T, Matsuoka H.
    J Hypertens; 2004 Jul 19; 22(7):1389-95. PubMed ID: 15201556
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.